Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Documenta Ophthalmologica
Published in: Documenta Ophthalmologica 2/2007

01-03-2007 | Case Report

The dilemma of the late-onset “Dystrophy”

Author: Michael F. Marmor

Published in: Documenta Ophthalmologica | Issue 2/2007

Login to get access

Abstract

A case of late-onset (age 51) visual loss and night-blindness is presented to illustrate the challenges of diagnosis. This patient had anti-enolase antibodies, and demonstrates the importance of auto-immune retinopathy as a potential cause of late-onset retinal “dystrophy.”
Literature
1.
Marmor MF, Holder GE, Seeliger MW, Yamamoto S. Standard for clinical electroretinography (2004 update). Doc Ophthalmol (2004) 108:107–114
2.
Marmor MF, Hood DC, Keating D, Kondo M, Seeliger MW, Miyake Y (2003) Guidelines for basic multifocal electroretinography (mfERG). Doc Ophthalmol 106:105–115PubMedCrossRef
3.
Kaplan J, Bonneau D, Frézal J, Munnich A, Duffer J-L (1990) Clinical and genetic heterogeneity in retinitis pigmentosa. Hum Genet 85:635–642PubMedCrossRef
4.
Michaelides M, Hardcastle AJ, Hunt DM, Moore AT. (2006) Progressive cone and cone-rod dystrophies: phenotypes and underlying molecular genetic basis. Surv Ophthalmol 51:232–258PubMedCrossRef
5.
Adamus G, Ren G, Weleber RG (2004) Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol 4:5PubMedCrossRef
6.
Whitcup SM, Vistica BP, Milam AH, Nussenblatt RB, Gery I (1998) Recoverin-associated retinopathy: a clinically and immunologically distinctive disease. Am J Ophthalmol 126:230–237PubMedCrossRef
7.
Weleber RG, Watzke RC, Shults WT, Trzupek KM, Heckenlively JR, Egan RA, Adamus G (2005) Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am J Ophthalmol 139:780–794PubMedCrossRef
Metadata
Title
The dilemma of the late-onset “Dystrophy”
Author
Michael F. Marmor
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Documenta Ophthalmologica / Issue 2/2007
Print ISSN: 0012-4486
Electronic ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-007-9046-0

Other articles of this Issue 2/2007

Documenta Ophthalmologica 2/2007 Go to the issue

Original Paper

Pattern VEPs before and after idiopathic epiretinal membrane removal

Original Paper

VEP asymmetry with ophthalmological and MRI findings in two achiasmatic children

Review Paper

A primer on motion visual evoked potentials

Original Research Article

Changes in multifocal oscillatory potentials after internal limiting membrane removal for macular hole